COAG Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Hemab Therapeutics Holdings Inc (COAG) Moving Averages Convergence Divergence (MACD) indicator is 0.0861, suggesting COAG is Strong Buy.

Hemab Therapeutics Holdings Inc (COAG) 20-Day simple moving average is 26.645, while Hemab Therapeutics Holdings Inc (COAG) share price is $29.24, making it Buy.

Hemab Therapeutics Holdings Inc (COAG) 60-Day simple moving average is 26.459, while Hemab Therapeutics Holdings Inc (COAG) share price is $29.24, making it Buy.

Technical Analysis for COAG

Technical Sentiment Analysis for Hemab Therapeutics Holdings Inc (COAG) As of 2026-06-18, Hemab Therapeutics Holdings Inc (COAG) is exhibiting a Strong Buy technical sentiment. Our proprietary analysis, which aggregates 13 technical signals, shows that 10 indicators are flashing buy, while 3 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for COAG stands at 62.635, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at 0.0861, providing a Buy signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 56.968 and the Commodity Channel Index (CCI) at 130.7 further confirm a 3.83 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, COAG is trading below its 60-day moving average of $26.459 and below its 200-day long-term moving average of $26.459. Key price levels to watch include the immediate resistance at $29.15 and strong support at $23.488. A break above $29.15 could signal a bull continuation, while falling below $23.488 may test the next Fibonacci floor at $20.817.

Hemab Therapeutics Holdings Inc (COAG) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	17.827	20.817	23.488	26.478	29.15	32.139	34.811
Fibonacci	20.817	22.979	24.315	26.478	28.641	29.977	32.139

Hemab Therapeutics Holdings Inc (COAG) Technical Indicators

2026-06-18

Name	Value
RSI_14	62.635
STOCHk_14_3_3	56.968
STOCHd_14_3_3	33.753
CCI_20	130.7
AO_5_34	-0.439
MOM_10	3.83
MACD_12_26_9	0.0861

Hemab Therapeutics Holdings Inc (COAG) Relative Strength Index (RSI) is 62.635, creating a Neutral signal.

Hemab Therapeutics Holdings Inc (COAG) Stochastic Oscillator is 56.968, creating a Neutral signal.

Hemab Therapeutics Holdings Inc (COAG) Stochastic RSI is 33.753, creating a Neutral signal.

Hemab Therapeutics Holdings Inc (COAG) Commodity Channel Index (CCI) is 130.7, creating a Sell signal.

Hemab Therapeutics Holdings Inc (COAG) Awesome Oscillator is -0.439, creating a Sell signal.

Hemab Therapeutics Holdings Inc (COAG) Momentum is 3.83, creating a Buy signal.

Hemab Therapeutics Holdings Inc (COAG) MACD is 0.0861, creating a Buy signal.

Hemab Therapeutics Holdings Inc (COAG) Moving Average

2026-06-18

Period	Simple	Signal
MA_5	26.252	Buy
MA_10	26.16	Buy
MA_20	26.645	Buy
MA_60	26.459	Buy
MA_200	26.459	Buy
MA_250	26.459	Buy

Hemab Therapeutics Holdings Inc (COAG) 5-Day simple moving average is 26.252, while Hemab Therapeutics Holdings Inc (COAG) share price is $29.24, making it a Buy.

Hemab Therapeutics Holdings Inc (COAG) 10-Day simple moving average is 26.16, while Hemab Therapeutics Holdings Inc (COAG) share price is $29.24, making it a Buy.

Hemab Therapeutics Holdings Inc (COAG) 20-Day simple moving average is 26.645, while Hemab Therapeutics Holdings Inc (COAG) share price is $29.24, making it a Buy.

Hemab Therapeutics Holdings Inc (COAG) 60-Day simple moving average is 26.459, while Hemab Therapeutics Holdings Inc (COAG) share price is $29.24, making it a Buy.

Hemab Therapeutics Holdings Inc (COAG) 200-Day simple moving average is 26.459, while Hemab Therapeutics Holdings Inc (COAG) share price is $29.24, making it a Buy.

Hemab Therapeutics Holdings Inc (COAG) 250-Day simple moving average is 26.459, while Hemab Therapeutics Holdings Inc (COAG) share price is $29.24, making it a Buy.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for COAG?

The overall technical consensus for Hemab Therapeutics Holdings Inc (COAG) is currently Strong Buy. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 4 buy signals and 3 sell signals.

What are the key support and resistance levels for Hemab Therapeutics Holdings Inc (COAG) today?

Based on pivot point calculations, Hemab Therapeutics Holdings Inc (COAG) has an immediate support level at 23.488 and a major resistance level at 29.15. Traders also monitor the pivot point at 26.478 to determine the intraday trend direction.

Is Hemab Therapeutics Holdings Inc (COAG) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Hemab Therapeutics Holdings Inc (COAG) is currently 62.635. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Hemab Therapeutics Holdings Inc (COAG)?

Hemab Therapeutics Holdings Inc (COAG) Moving Averages Convergence Divergence (MACD) indicator is 0.0861, suggesting COAG is Strong Buy. This indicator helps identify potential trend reversals or momentum shifts for Hemab Therapeutics Holdings Inc.

How is Hemab Therapeutics Holdings Inc (COAG) performing relative to its 200-day moving average?

Hemab Therapeutics Holdings Inc (COAG) is currently trading at $29.24, which is above its 200-day simple moving average of 26.459. Trading above the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.